These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy. Lucke IM, Wieske L, van der Kooi AJ, van Schaik IN, Eftimov F, Verhamme C. J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121 [Abstract] [Full Text] [Related]
6. Comparison of Lewis-Sumner syndrome with chronic inflammatory demyelinating polyradiculoneuropathy patients in a tertiary care centre. Fargeot G, Maisonobe T, Psimaras D, Debs R, Lenglet T, Adams D, Vandendries C, Labeyrie C, Viala K. Eur J Neurol; 2020 Mar; 27(3):522-528. PubMed ID: 31574194 [Abstract] [Full Text] [Related]
7. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy. Kaplan A, Brannagan TH. Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215 [Abstract] [Full Text] [Related]
8. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. Mauermann ML, Sorenson EJ, Dispenzieri A, Mandrekar J, Suarez GA, Dyck PJ, Dyck PJ. J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441 [Abstract] [Full Text] [Related]
10. Treatment response in patients with clinical and supportive laboratory features of chronic inflammatory demyelinating polyneuropathy without demyelinative findings on nerve conduction studies: A retrospective study. Curry P, Herrmann DN, Stanton M, Mongiovi P, Akmyradov C, Logigian E. Muscle Nerve; 2024 Nov; 70(5):1082-1088. PubMed ID: 38958279 [Abstract] [Full Text] [Related]
11. Characteristics and correlates of sensory function in chronic inflammatory demyelinating polyneuropathy. Rajabally YA, Narasimhan M. J Neurol Sci; 2010 Oct 15; 297(1-2):11-4. PubMed ID: 20673919 [Abstract] [Full Text] [Related]
13. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy]. Shimizu F, Nemoto J, Takeshita Y, Maeda T, Koga M, Kanda T. Rinsho Shinkeigaku; 2022 Mar 29; 62(3):173-177. PubMed ID: 35228460 [Abstract] [Full Text] [Related]
14. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy. Rajabally YA, Narasimhan M. Eur J Neurol; 2011 Feb 29; 18(2):293-299. PubMed ID: 20602631 [Abstract] [Full Text] [Related]
15. Sensory CIDP presenting as cryptogenic sensory polyneuropathy. Chin RL, Latov N, Sander HW, Hays AP, Croul SE, Magda P, Brannagan TH. J Peripher Nerv Syst; 2004 Sep 29; 9(3):132-7. PubMed ID: 15363060 [Abstract] [Full Text] [Related]
16. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy. Rajabally YA, Jacob S. Clin Neurophysiol; 2006 Sep 29; 117(9):2079-84. PubMed ID: 16859987 [Abstract] [Full Text] [Related]
17. Diagnostic utility of somatosensory evoked potentials in chronic polyradiculopathy without electrodiagnostic signs of peripheral demyelination. Devic P, Petiot P, Mauguiere F. Muscle Nerve; 2016 Jan 29; 53(1):78-83. PubMed ID: 25908550 [Abstract] [Full Text] [Related]
19. Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. Silwal A, Pitt M, Phadke R, Mankad K, Davison JE, Rossor A, DeVile C, Reilly MM, Manzur AY, Muntoni F, Munot P. Neuromuscul Disord; 2018 Sep 29; 28(9):757-765. PubMed ID: 30072201 [Abstract] [Full Text] [Related]
20. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? Capasso M, Torrieri F, Di Muzio A, De Angelis MV, Lugaresi A, Uncini A. Clin Neurophysiol; 2002 Mar 29; 113(3):346-53. PubMed ID: 11897535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]